TP53 and nonpapillary renal cell carcinoma: Transcriptomics and lipidomics, alongside ROS, ferroptosis, and p53 inhibitors, were applied to uncover mechanisms.<h4>Results</h4>ACSL1 is markedly downregulated in ccRCC and predicts poor prognosis.